Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?

John Armato, Ralph A. DeFronzo, Shih Ting Chiu, Deanna Rider, Ronald Ruby

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2465-2468
Number of pages4
JournalDiabetes, Obesity and Metabolism
Volume24
Issue number12
DOIs
StatePublished - Dec 2022

Keywords

  • ACE inhibitor
  • SARS-CoV-2
  • angiotensin receptor blocker

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this